Garrigues
Garrigues‘ ’extraordinary‘ practice handles a broad range of matters for medical device and healthcare product manufacturers, pharma and biotech companies, and both public and private hospitals. Practice head José Fernández-Rañada is known for his extensive corporate expertise, regularly advising on M&A, spin-offs, and corporate restructurings. Carolina Pina is the main contact for IP-related matters, while Javier Manchado primarily advises public authorities and private companies on public procurement issues, particularly in relation to the award and performance of public sector contracts.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Extraordinary, long-term and successful experience makes this firm a benchmark in the life sciences sector.’
‘Their knowledge of the pharmaceutical sector, culture and the client's business is excellent, which makes us real partners when it comes to facing the issues and challenges that arise.’
‘We have been working with Garrigues for many years. They have always responded quickly, successfully and with quality work. The team is very synchronised, offering constant support in different areas and friendly treatment.’
‘The main advantage we have with Garrigues is its very extensive knowledge of the client and their particular circumstances. The team's best qualities are the closeness and personalised treatment it offers both at the partner, associate and junior level.’
‘As outstanding partners, I would highlight Jose Fernández-Rañada and Juan Manuel Cabeza, two people with a lot of experience and technical knowledge of the healthcare/pharmaceutical industry.’
‘We are fully satisfied with the treatment, diligence and service.’
‘Direct treatment and excellent attention.’
Key clients
- Noucor Group
- Sanofi
- Eisai
- Roche
- IVI RMA
- Farmaindustria
- Shockwave Medical
- GSK (Glaxosmithkline)
- Baxter, S.L.
- Astrazeneca Farmaceútica Spain, S.A.
Work highlights
- Advised IVI RMA on its sale to KKR.
- Advised Centene Corporation on the sale of its Spanish and Central European businesses (including the Valencian group Ribera Salud) to Vivalto Santé.
- Advised Fluidra Finco on the cross-border merger by absorption of French company ZPNA Holdings, S.A.S.
Practice head
The lawyer(s) leading their teams.
José Fernández-Rañada